Stocks and Investing
Stocks and Investing
Thu, January 28, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Marie Thibault Upgraded (ABT) to Strong Buy and Held Target at $140 on, Jan 28th, 2021
Marie Thibault of BTIG, Upgraded "Abbott Laboratories" (ABT) to Strong Buy and Held Target at $140 on, Jan 28th, 2021.
Marie has made no other calls on ABT in the last 4 months.
There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 0 agree with Marie's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Marie
- Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $122 on, Thursday, October 22nd, 2020
- Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $120 on, Wednesday, October 21st, 2020
- Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $125 on, Friday, October 9th, 2020
Contributing Sources